Journal article icon

Journal article

TaleNeprilysin and Neprilysin inhibition in chronic kidney disease

Abstract:

Purpose of review

Chronic kidney disease (CKD) is associated with increased risk of progression to end-stage kidney disease and cardiovascular events. There is limited evidence that available treatments have beneficial effects on cardiorenal outcomes in all people with nondiabetic CKD. Neprilysin inhibition (NEPi) is a new therapeutic strategy with potential to improve outcomes for patients with CKD.

Recent findings

NEPi enhances the activity... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1097/mnh.0000000000000659

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
ORCID:
0000-0002-1179-0023
Publisher:
Lippincott, Williams & Wilkins
Journal:
Current Opinion in Nephrology and Hypertension More from this journal
Volume:
30
Issue:
1
Pages:
123-130
Publication date:
2021-11-03
Acceptance date:
2021-11-01
DOI:
EISSN:
1473-6543
ISSN:
1062-4821
Pmid:
33148948
Language:
English
Keywords:
Pubs id:
1145908
Local pid:
pubs:1145908
Deposit date:
2023-02-02

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP